Protocol For A Research Database For Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01166009 |
Recruitment Status :
Recruiting
First Posted : July 20, 2010
Last Update Posted : July 24, 2019
|
Sponsor:
Center for International Blood and Marrow Transplant Research
Information provided by (Responsible Party):
Center for International Blood and Marrow Transplant Research
Tracking Information | |||||
---|---|---|---|---|---|
First Submitted Date | July 16, 2010 | ||||
First Posted Date | July 20, 2010 | ||||
Last Update Posted Date | July 24, 2019 | ||||
Study Start Date | July 2002 | ||||
Estimated Primary Completion Date | July 2025 (Final data collection date for primary outcome measure) | ||||
Current Primary Outcome Measures |
A Comprehensive Source of Observational Data to assess Stem Cell Transplant [ Time Frame: Anually - on average ] A primary outcome is to have a comprehensive source of stem cell transplant data that can be used to assess topics such as:
|
||||
Original Primary Outcome Measures | Same as current | ||||
Change History | Complete list of historical versions of study NCT01166009 on ClinicalTrials.gov Archive Site | ||||
Current Secondary Outcome Measures |
A Comprehensive Source of Data for Marrow Toxic Injuries [ Time Frame: anually- on average ] | ||||
Original Secondary Outcome Measures | Same as current | ||||
Current Other Pre-specified Outcome Measures | Not Provided | ||||
Original Other Pre-specified Outcome Measures | Not Provided | ||||
Descriptive Information | |||||
Brief Title | Protocol For A Research Database For Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries | ||||
Official Title | Protocol For A Research Database For Hematopoietic Stem Cell Transplantation, Other Cellular Therapies and Marrow Toxic Injuries | ||||
Brief Summary | The primary purpose of the Research Database is to have a comprehensive source of observational data that can be used to study HSC transplantation and cellular therapies. A secondary purpose of the Research Database is to have a comprehensive source of data to study marrow toxic injuries. Objectives: To learn more about what makes stem cell transplants and cellular therapies work well such as:
|
||||
Detailed Description | Not Provided | ||||
Study Type | Observational | ||||
Study Design | Observational Model: Cohort Time Perspective: Retrospective |
||||
Target Follow-Up Duration | Not Provided | ||||
Biospecimen | Not Provided | ||||
Sampling Method | Non-Probability Sample | ||||
Study Population | Recipients and Donors that are involved with a stem cell transplantation process. | ||||
Condition |
|
||||
Intervention | Not Provided | ||||
Study Groups/Cohorts | Not Provided | ||||
Publications * | Not Provided | ||||
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
Recruitment Information | |||||
Recruitment Status | Recruiting | ||||
Estimated Enrollment |
99999999 | ||||
Original Estimated Enrollment | Same as current | ||||
Estimated Study Completion Date | July 2025 | ||||
Estimated Primary Completion Date | July 2025 (Final data collection date for primary outcome measure) | ||||
Eligibility Criteria | Eligibility to Participate in the Research Database Recipient Eligibility Criteria:
Individual with Marrow Toxic Injury Eligibility Criteria:
Unrelated Donor Eligibility Criteria:
|
||||
Sex/Gender |
|
||||
Ages | Child, Adult, Older Adult | ||||
Accepts Healthy Volunteers | No | ||||
Contacts |
|
||||
Listed Location Countries | United States | ||||
Removed Location Countries | |||||
Administrative Information | |||||
NCT Number | NCT01166009 | ||||
Other Study ID Numbers | NMDP IRB-1999-0021 | ||||
Has Data Monitoring Committee | No | ||||
U.S. FDA-regulated Product | Not Provided | ||||
IPD Sharing Statement | Not Provided | ||||
Responsible Party | Center for International Blood and Marrow Transplant Research | ||||
Study Sponsor | Center for International Blood and Marrow Transplant Research | ||||
Collaborators | Not Provided | ||||
Investigators |
|
||||
PRS Account | Center for International Blood and Marrow Transplant Research | ||||
Verification Date | July 2019 |